Medtronic

StarFish Contribution

Delivered a production ready wearable insulin pump and collaborated closely with MiniMed’s internal team to support design transfer. Continued providing manufacturing support through their acquisition by Medtronic, contributing to the product’s success and helping establish a leading position in wearable insulin delivery.

$100M Valuation

Medtronic acquired MiniMed in 2001 for $3.3 billion, marking one of the largest transaction in the diabetes care industry. The MiniMed insulin pump technology remains a cornerstone of Medtronic’s diabetes management portfolio, helping millions achieve better glucose control and quality of life.